These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The Nbeal2(-/-) mouse as a model for the gray platelet syndrome. Deppermann C; Nurden P; Nurden AT; Nieswandt B; Stegner D Rare Dis; 2013; 1():e26561. PubMed ID: 25003009 [TBL] [Abstract][Full Text] [Related]
24. Platelet α-granules modulate the inflammatory response under systemic lipopolysaccharide injection in mice. Tariket S; Guerrero JA; Garraud O; Ghevaert C; Cognasse F Transfusion; 2019 Jan; 59(1):32-38. PubMed ID: 30394544 [TBL] [Abstract][Full Text] [Related]
25. Comparing the levels of CTLA-4-dependent biological defects in patients with LRBA deficiency and CTLA-4 insufficiency. Catak MC; Akcam B; Bilgic Eltan S; Babayeva R; Karakus IS; Akgun G; Baser D; Bulutoglu A; Bayram F; Kasap N; Kiykim A; Hancioglu G; Kokcu Karadag SI; Kendir Demirkol Y; Ozen S; Cekic S; Ozcan D; Edeer Karaca N; Sasihuseyinoglu AS; Cansever M; Ozek Yucel E; Tamay Z; Altintas DU; Aydogmus C; Celmeli F; Cokugras H; Gulez N; Genel F; Metin A; Guner SN; Kutukculer N; Keles S; Reisli I; Kilic SS; Yildiran A; Karakoc-Aydiner E; Lo B; Ozen A; Baris S Allergy; 2022 Oct; 77(10):3108-3123. PubMed ID: 35491430 [TBL] [Abstract][Full Text] [Related]
26. Immunological phenotype of the murine Lrba knockout. Gámez-Díaz L; Neumann J; Jäger F; Proietti M; Felber F; Soulas-Sprauel P; Perruzza L; Grassi F; Kögl T; Aichele P; Kilimann M; Grimbacher B; Jung S Immunol Cell Biol; 2017 Oct; 95(9):789-802. PubMed ID: 28652580 [TBL] [Abstract][Full Text] [Related]
30. Clinical Phenotypes and Immunological Characteristics of 18 Egyptian LRBA Deficiency Patients. Meshaal S; El Hawary R; Adel R; Abd Elaziz D; Erfan A; Lotfy S; Hafez M; Hassan M; Johnson M; Rojas-Restrepo J; Gamez-Diaz L; Grimbacher B; Shoman W; Abdelmeguid Y; Boutros J; Galal N; El-Guindy N; Elmarsafy A J Clin Immunol; 2020 Aug; 40(6):820-832. PubMed ID: 32506362 [TBL] [Abstract][Full Text] [Related]
31. Mutations in Neurobeachin-like 2 do not impact Weibel-Palade body biogenesis and von Willebrand factor secretion in gray platelet syndrome Endothelial Colony Forming Cells. Kat M; van Moort I; Bürgisser PE; Kuijpers TW; Hofman M; Favier M; Favier R; Margadant C; Voorberg J; Bierings R Res Pract Thromb Haemost; 2023 Feb; 7(2):100086. PubMed ID: 36923710 [TBL] [Abstract][Full Text] [Related]
32. Gray platelet syndrome: NBEAL2 mutations are associated with pathology beyond megakaryocyte and platelet function defects. Pluthero FG; Kahr WHA J Thromb Haemost; 2021 Feb; 19(2):318-322. PubMed ID: 33300270 [No Abstract] [Full Text] [Related]
36. The Neurobeachin-like 2 protein (NBEAL2) controls the homeostatic level of the ribosomal protein RPS6 in mast cells. Wegner P; Drube J; Ziegler L; Strotmann B; Marquardt R; Küchler C; Groth M; Nieswandt B; Andreas N; Drube S Immunology; 2024 May; 172(1):61-76. PubMed ID: 38272677 [TBL] [Abstract][Full Text] [Related]